Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+ T-cell response, prominent infiltration of CD8+ lymphocytes and Th1 type polarization

被引:45
作者
Ranki, Tuuli [1 ]
Joensuu, Timo [2 ]
Jaeger, Elke [3 ]
Karbach, Julia [3 ]
Wahle, Claudia [3 ]
Kairemo, Kalevi [2 ]
Alanko, Tuomo [2 ]
Partanen, Kaarina [2 ]
Turkki, Riku [4 ]
Linder, Nina [4 ]
Lundin, Johan [4 ]
Ristimaki, Ari [5 ,6 ,7 ]
Kankainen, Matti [4 ]
Hemminki, Akseli [8 ]
Backman, Charlotta [1 ]
Dienel, Kasper [1 ]
von Euler, Mikael [1 ]
Haavisto, Elina [1 ]
Hakonen, Tiina [1 ]
Juhila, Juuso [1 ]
Jaderberg, Magnus [1 ]
Priha, Petri [1 ]
Vassilev, Lotta [1 ]
Vuolanto, Antti [1 ]
Pesonen, Sari [1 ]
机构
[1] Oncos Therapeut, Helsinki, Finland
[2] Docrates Canc Ctr, Helsinki, Finland
[3] Krankenhaus NW Frankfurt, Frankfurt, Germany
[4] Inst Mol Med Finland FIMM, Helsinki, Finland
[5] Univ Helsinki, Cent Hosp, Div Pathol, HUSLAB, Helsinki, Finland
[6] Univ Helsinki, Cent Hosp, Haartman Inst, Helsinki, Finland
[7] Univ Helsinki, Res Programs Unit, Helsinki, Finland
[8] Univ Helsinki, Haartman Inst, Canc Gene Therapy Grp, Helsinki, Finland
来源
ONCOIMMUNOLOGY | 2014年 / 3卷 / 10期
关键词
Adenovirus; antitumor immunity; cytotoxic immunotherapy; GM-CSF; Th1; polarization; tumor infiltrating lymphocytes;
D O I
10.4161/21624011.2014.958937
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Late stage cancer is often associated with reduced immune recognition and a highly immunosuppressive tumor microenvironment. The presence of tumor infiltrating lymphocytes (TILs) and specific gene-signatures prior to treatment are linked to good prognosis, while the opposite is true for extensive immunosuppression. The use of adenoviruses as cancer vaccines is a form of active immunotherapy to initialise a tumor-specific immune response that targets the patient's unique tumor antigen repertoire. We report a case of a 68-year-old male with asbestos-related malignant pleural mesothelioma who was treated in a Phase I study with a granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing oncolytic adenovirus, Ad5/3-D24-GMCSF (ONCOS-102). The treatment resulted in prominent infiltration of CD8(+) lymphocytes to tumor, marked induction of systemic antitumor CD8C T-cells and induction of Th1-type polarization in the tumor. These results indicate that ONCOS-102 treatment sensitizes tumors to other immunotherapies by inducing a T-cell positive phenotype to an initially T-cell negative tumor.
引用
收藏
页码:e958937 / 1
页数:4
相关论文
共 21 条
[21]   STC1 encapsulated in small extracellular vesicles from laryngeal squamous cell carcinoma cells induces CD8+ T cell dysfunction by reprogramming tumor-associated macrophages into M2-like macrophages [J].
Chen, Xiaoxue ;
Zhao, Zhigang ;
Zhao, Rui ;
Li, Wenjing ;
Liu, Xinyu ;
Tian, Linli ;
Liu, Ming .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (02)